Discover trends, market shifts, and competitive outlooks for the ace inhibitors industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has The ACE Inhibitors Market Size Shifted, And What Is the Outlook Through 2034?

In recent times, the market size for ACE inhibitors has seen consistent growth. A rise from $7.15 billion in 2024 to $7.48 billion in 2025 is projected, demonstrating a compound annual growth rate (CAGR) of 4.6%. The historical growth can be linked to several factors, namely an increase in cardiovascular disease occurrence, a growing aging population, proven clinical efficacy and safety, diabetes prevalence, regulatory approvals and established guidelines.

The market size for ACE inhibitors is anticipated to experience robust growth in the upcoming years, reaching a value of $9.6 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 6.4%. The driving factors behind this projected growth for the forecasted period include an increased worldwide prevalence of cardiovascular diseases, broadened hypertension treatment guidelines, advancements in combined therapies, a heightened concentration on heart failure management, and increased accessibility and awareness of healthcare. Major trends that are expected to shape the landscape during the forecast period involve a focus on kidneys’ protection, favoring renin-angiotensin system inhibitors, competition from generic brands resulting in pricing pressures, patient-oriented strategies in healthcare, and modifications in regulations and safety aspects.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10671&type=smp

Which Primay Drivers Are Accelerating Growth in the ACE Inhibitors Market?

The growth of the ACE inhibitors market is anticipated to be fuelled by the rising incidence of hypertension disorders. Hypertension, also known medically as high blood pressure, is defined by increased pressure levels in the blood vessels. ACE inhibitors, or angiotensin-converting enzyme inhibitors as they are often called, are a classification of drugs that are used in the management of hypertension. They work by relaxing the blood vessels, which in turn reduces blood pressure and enhances blood circulation. As per the World Health Organization, a United Nations specialized agency based in Switzerland, approximately 1.28 billion adults aged between 30 and 79 were diagnosed with hypertension across the globe as of March 2023. This group predominantly (two-thirds) consists of people living in low-to-middle income countries. Over the recent 30 years, a staggering increase of 650 million people between the ages 30 to 79 have been diagnosed with hypertension. Astonishingly, an estimated 46% of these adults remain unaware of their condition due to lack of diagnosis. Consequently, this rising prevalence of hypertension disorders is propelling the growth of the ACE inhibitors market.

Which Primary Segments of the ACE Inhibitors Market Are Driving Growth and Industry Transformations?

The ACE inhibitors market covered in this report is segmented –

1) By Type: Sulfhydryl-containing Agents, Dicarboxylate-containing Agents, Phosphonate-containing Agents

2) By Drug: Ramipril, Enalapril, Benazepril, Fosinopril, Captopril, Moexipril, Other Drugs

3) By Dosage Form: Oral Tablets, Oral Solutions

4) By Application: Heart Failure, Chronic Kidney Disease, Hypertension, Diabetes, Heart Attack, Other Applications

5) By End-Users: Hospitals, Online Drug Stores, Other End-Users

Subsegments:

1) By Sulfhydryl-Containing Agents: Captopril, Zofenopril

2) By Dicarboxylate-Containing Agents: Enalapril, Lisinopril, Ramipril, Quinapril, Benazepril, Perindopril

3) By Phosphonate-Containing Agents: Fosinopril

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=10671&type=smp

Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the ACE Inhibitors Market?# Market?

North America was the largest region in the ACE inhibitors market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global ACE inhibitors market report during the forecast period. The regions covered in the ace inhibitors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Which Technological Trends Are Reshaping the ACE Inhibitors Industry Dynamics?

Emerging as a notable trend in the ACE inhibitors market space, product innovations are becoming increasingly important. Positioned on the goal of consolidating their hold and acquiring an edge over competitors, major firms in the ACE inhibitors market are committed to creating cutting-edge products. An example of this happened in February 2023 when Travere Therapeutics, an American biopharmaceutical entity, received FDA endorsement for FILSPARI (sparsentan). This novel non-immunosuppressive therapy is suited for IgA nephropathy (IgAN) patients. The treatment measures used include systemic glucocorticoids, ACE inhibitors, and antihypertensive drugs such as angiotensin-receptor blockers (ARBs). The standout feature of this therapy is its status as the only non-immunosuppressive treatment approved. It serves as a once-a-day oral medicine formulated for adults with primary IgAN, who are prone to quick disease progression and usually show a UPCR less than 1.5 g/g and proteinuria.

View the full report here:

https://www.thebusinessresearchcompany.com/report/ace-inhibitors-global-market-report

What Parameters Are Used to Define the ACE Inhibitors Market?

ACE inhibitors, also known as angiotensin-converting enzyme (ACE) inhibitors, refer to a type of medication used to treat and manage hypertension. They function by stopping the body’s enzyme from generating angiotensin II, a chemical that constricts blood vessels and raises blood pressure. Its basic function is to relax the veins and arteries to reduce blood pressure.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10671

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model